EBR Systems, Inc.

EBRCZ OTC CIK: 0001347123

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 480 OAKMEAD PARKWAY, SUNNYVALE, CA, 94085
Mailing Address 480 OAKMEAD PARKWAY, SUNNYVALE, CA, 94085
Phone 408 720-1906
Fiscal Year End 1231
EIN 571164669

Recent SEC Filings

Form Type Date Filed Document
DEF 14A Definitive proxy statement March 26, 2026 View on SEC
8-K Current report of material events March 26, 2026 View on SEC
4 Insider stock transaction report March 25, 2026 View on SEC
10-K Annual financial report March 18, 2026 View on SEC
8-K Current report of material events March 13, 2026 View on SEC
4 Insider stock transaction report March 6, 2026 View on SEC
DEF 14A Definitive proxy statement January 26, 2026 View on SEC
8-K Current report of material events January 13, 2026 View on SEC
10-Q Quarterly financial report November 12, 2025 View on SEC
4 Insider stock transaction report August 19, 2025 View on SEC

Annual Reports

10-K March 18, 2026
  • Achieved 120% revenue growth to $18.5 million for the fiscal year ended December 31, 2025.
  • Expanded market access with full reimbursement in Germany and commercial launches in France and Italy for the WiSE™ CRT System.
View Analysis

Material Events

8-K Strategy Change March 13, 2026
High Impact
  • Successfully raised A$55.9 million (US$36.3 million) through CDI issuance, significantly extending financial runway.
  • Shareholders approved authorization for a reverse stock split, potentially enabling the company to meet exchange listing requirements and attract institutional investors.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.